Jump to main content
Jump to site search

Issue 27, 2017
Previous Article Next Article

Targeting heparin and heparan sulfate protein interactions

Author affiliations

Abstract

Heparin and heparan sulfate glycosaminoglycans are long, linear polysaccharides that are made up of alternating dissacharide sequences of sulfated uronic acid and amino sugars. Unlike heparin, which is only found in mast cells, heparan sulfate is ubiquitously expressed on the cell surface and in the extracellular matrix of all animal cells. These negatively-charged glycans play essential roles in important cellular functions such as cell growth, adhesion, angiogenesis, and blood coagulation. These biomolecules are also involved in pathophysiological conditions such as pathogen infection and human disease. This review discusses past and current methods for targeting these complex biomolecules as a novel therapeutic strategy to treating disorders such as cancer, neurodegenerative diseases, and infection.

Graphical abstract: Targeting heparin and heparan sulfate protein interactions

Back to tab navigation

Publication details

The article was received on 02 May 2017, accepted on 13 Jun 2017 and first published on 13 Jun 2017


Article type: Review Article
DOI: 10.1039/C7OB01058C
Citation: Org. Biomol. Chem., 2017,15, 5656-5668
  •   Request permissions

    Targeting heparin and heparan sulfate protein interactions

    R. J. Weiss, J. D. Esko and Y. Tor, Org. Biomol. Chem., 2017, 15, 5656
    DOI: 10.1039/C7OB01058C

Search articles by author

Spotlight

Advertisements